Buys
Open market- Shares
- Avg price
- Total value
Fady Ibraham Malik - EVP Research & Development at CYTOKINETICS INC
Issuer-level insider activity
- Role
- EVP Research & Development
- Issuer ticker
- CYTK on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Fady Ibraham Malik in CYTOKINETICS INC
Sells
Open market- Shares
- -64,440
- Avg price
- $67.55
- Total value
- -$4,352,750
Net
Past year- Shares
- -64,440
- Share %
- -100%
- Total value
- -$4,352,750
Reported holdings for Fady Ibraham Malik in CYTOKINETICS INC
Form 4 holding
EVP Research & Development
CYTOKINETICS INC
- Security class
- Common Stock
- Shares / value
- 153,902
- Estimated value
- $11,668,849
- Report date
- 18 Aug 2026
- Price
- $75.82
- Ownership
- Direct
Form 4 holding
EVP Research & Development
CYTOKINETICS INC
- Security class
- Non-Qualified Stock Option (Right to Buy)
- Shares / value
- 30,386
- Estimated value
- Report date
- 18 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP Research & Development
CYTOKINETICS INC
- Security class
- Incentive Stock Option (Right to Buy)
- Shares / value
- 1,665
- Estimated value
- Report date
- 15 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Fady Ibraham Malik in CYTOKINETICS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.